Mesoblast (MESO) Common Equity (2014 - 2026)
Mesoblast (MESO) posted Common Equity of $568.41 million for the quarter ended Jun 30, 2026, down 4.9% from $597.44 million a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Common Equity (2014 - 2026) Analysis & Trends
Since the quarter ended Jun 30, 2015, Mesoblast has reported Common Equity for 39 quarters.
- Annual Common Equity shows a five-year compound annual growth rate of -0.5% (years ended Jun 2021 to Jun 2026).
- In prior years, Mesoblast's Common Equity was $597.44 million in the year ended Jun 30, 2025 (+24.4%), $480.36 million in the year ended Jun 30, 2024 (-4.3%), $501.84 million in the year ended Jun 30, 2023 (+1.0%) and $497.04 million in the year ended Jun 30, 2022 (-14.5%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Common Equity since the quarter ended Dec 31, 2024.
- On a year-over-year basis, Common Equity increased in two of the last four quarters, with growth averaging 8.7%.
- The strongest year-over-year quarter for Common Equity in the past five years was the quarter ended Dec 31, 2025, with growth of 24.6%; the weakest was the quarter ended Jun 30, 2022, with a decline of 14.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Mesoblast | 1.84 Bn | 1.40 Bn | - | 568.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 568.41 Mn |
| Dec 31, 2025 | 574.68 Mn |
| Jun 30, 2025 | 597.44 Mn |
| Dec 31, 2024 | 461.26 Mn |
| Jun 30, 2024 | 480.36 Mn |
| Dec 31, 2023 | 508.73 Mn |
| Jun 30, 2023 | 501.84 Mn |
| Mar 31, 2023 | 482.17 Mn |
| Dec 31, 2022 | 500.00 Mn |
| Sep 30, 2022 | 522.81 Mn |
| Jun 30, 2022 | 497.04 Mn |
| Mar 31, 2022 | 517.13 Mn |
| Dec 31, 2021 | 535.51 Mn |
| Sep 30, 2021 | 559.75 Mn |
| Jun 30, 2021 | 581.40 Mn |
| Mar 31, 2021 | 600.93 Mn |
| Dec 31, 2020 | 518.73 Mn |
| Sep 30, 2020 | 538.51 Mn |
| Jun 30, 2020 | 549.33 Mn |
| Mar 31, 2020 | 487.81 Mn |
API Access
Mesoblast Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();